Marten Siemelink (@martensiemelink) 's Twitter Profile
Marten Siemelink

@martensiemelink

Innovation manager @ Genetics Department, UMC Utrecht. MD, PhD.

ID: 568929841

calendar_today02-05-2012 08:41:10

1,1K Tweet

352 Followers

432 Following

Luiza Jarovsky (@luizajarovsky) 's Twitter Profile Photo

🚨BREAKING: The European Parliament has just APPROVED the AI Act. What everyone should know: ➵ The AI Act follows a risk-based approach. Some AI systems are banned, such as those involving: - Cognitive behavioral manipulation of people or specific vulnerable groups; - Social

🚨BREAKING: The European Parliament has just APPROVED the AI Act. What everyone should know:

➵ The AI Act follows a risk-based approach. Some AI systems are banned, such as those involving:

- Cognitive behavioral manipulation of people or specific vulnerable groups;
- Social
Panteleimon ("Paddy") Ekkekakis (@ekkekakis) 's Twitter Profile Photo

Remember: Manuscripts are *closely* scrutinized by at least two peer reviewers, then carefully read by at least one editor, then inspected with a fine-tooth comb by a qualified copyeditor, and finally the galley proofs are double-triple checked by the authors one last time.

Remember: Manuscripts are *closely* scrutinized by at least two peer reviewers, then carefully read by at least one editor, then inspected with a fine-tooth comb by a qualified copyeditor, and finally the galley proofs are double-triple checked by the authors one last time.
Jeremy Nguyen ✍🏼 🚢 (@jeremynguyenphd) 's Twitter Profile Photo

Are medical studies being written with ChatGPT? Well, we all know ChatGPT overuses the word "delve". Look below at how often the word 'delve' is used in papers on PubMed (2023 was the first full year of ChatGPT).

Are medical studies being written with ChatGPT? 

Well, we all know ChatGPT overuses the word "delve".

Look below at how often the word 'delve' is used in papers on PubMed (2023 was the first full year of ChatGPT).
Marten Siemelink (@martensiemelink) 's Twitter Profile Photo

Important message from Kaitlin Samocha at #ESHG2024: Still none of the large databases have good representation of worldwide population ancestries

Important message from Kaitlin Samocha at #ESHG2024: Still none of the large databases have good representation of worldwide population ancestries
Marten Siemelink (@martensiemelink) 's Twitter Profile Photo

Alexander Hoischen at #ESHG2024 jokingly quoting Han Brunner: "Doctors are great - Exomes are often better" 😄 Adding that longread exomes are even better

Alexander Hoischen at #ESHG2024 jokingly quoting Han Brunner: "Doctors are great - Exomes are often better" 😄 Adding that longread exomes are even better
Marten Siemelink (@martensiemelink) 's Twitter Profile Photo

Pharmacogenetic testing is also important for new rare-disease treatments, like CYP2C19 for the use of Mavacamten in HCM. Miriam Elbracht at #ESHG2024

Pharmacogenetic testing is also important for new rare-disease treatments, like CYP2C19 for the use of Mavacamten in HCM. Miriam Elbracht at #ESHG2024
Marten Siemelink (@martensiemelink) 's Twitter Profile Photo

Hellen Lesman shows that training on diverse ancestry improves the accuracy of Gestaltmatcher in facial recognition across global populations. #ESHG2024

Hellen Lesman shows that training on diverse ancestry improves the accuracy of Gestaltmatcher in facial recognition across global populations. #ESHG2024
Marten Siemelink (@martensiemelink) 's Twitter Profile Photo

Lupski, who made great contributions CNVs and Dosage effects, continues the #ESHG2024 Mendel lecture with a bit of sobering advice about great discoveries :)

Lupski, who made great contributions CNVs and Dosage effects, continues the #ESHG2024 Mendel lecture with a bit of sobering advice about great discoveries :)
Marten Siemelink (@martensiemelink) 's Twitter Profile Photo

Lupski, finishing off with a great call to action: "85% of the annotated genes in the assayable portion of the human genome are without a clinical phenotype associated to pathogenic variation - let's get to work" #ESHG2024